A Case of Novel GATA-1 Mutation-positive Transient Abnormal Myelopoiesis With Life-threatening Complications in a Neonate With Down Syndrome.

Transient abnormal myelopoiesis is a transient myeloproliferative disorder seen in ∼15% to 20% of infants with Down syndrome. These infants are usually asymptomatic, requiring only monitoring, but they can have variable severity of symptoms up to multisystemic dysfunction requiring chemotherapy. GATA-1 somatic mutations acquired in utero are pathognomic of this entity and present nearly in all cases. Herein, we present a case of Down syndrome in a neonate who presented within her first week of life with life-threatening features of transient abnormal myelopoiesis requiring chemotherapy support. In addition, next-generation sequencing revealed a small mutant clone (8%) positive for a novel frameshift GATA-1 mutation. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Citation

Ritesh R Sah, Somosri Ray, Prateek Bhatia, Shashi K Dhir, Sidharth Totadri, Narender Kumar, Praveen Kumar. A Case of Novel GATA-1 Mutation-positive Transient Abnormal Myelopoiesis With Life-threatening Complications in a Neonate With Down Syndrome. Journal of pediatric hematology/oncology. 2021 Mar 01;43(2):e292-e295

Mesh Tags

Substances

PMID: 31876781

search → result